Genetic polymorphism of glutathione S-transferase T1 and the risk of colorectal cancer: A meta-analysis

Cancer Epidemiology

Volumn 34, Issue 1, 2010, Pages 66-72

  Wan, Hongwei ^a   Zhou, Yong ^b   Yang, Ping ^a   Chen, Bo ^a   Jia, Guiqing ^a   Wu, Xiaoting ^b  

^a SICHUAN UNIVERSITY   (China)

^b SICHUAN UNIVERSITY   (China)

Author keywords

Colorectal cancer; Glutathione S transferase; GSTT1; Meta analysis; Polymorphism

Indexed keywords

GLUTATHIONE TRANSFERASE T1;

ADULT; AGED; ARTICLE; CANCER RISK; COLON CANCER; COLORECTAL CANCER; CONTROLLED STUDY; ETHNIC DIFFERENCE; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RECTUM CANCER;

AGED; COLORECTAL NEOPLASMS; GLUTATHIONE TRANSFERASE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; RISK FACTORS;

EID: 76449106977     PISSN: 18777821     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canep.2009.12.006     Document Type: Article

References (65)

1. Parkin D.M., Bray F., Ferlay J., and Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 55 (2005) 74-108
2. Parkin D.M., Bray F.I., and Devesa S.S. Cancer burden in the year 2000. The global picture. Eur J Cancer 37 (2001) S4-66
3. Sung J.J., Lau J.Y., Goh K.L., and Leung W.K. Increasing incidence of colorectal cancer in Asia: implications for screening. Lancet Oncol 6 (2005) 871-876
4. Giacosa A., Franceschi S., La Vecchia C., Favero A., and Andreatta R. Energy intake, overweight, physical exercise and colorectal cancer risk. Eur J Cancer Prev 8 (1999) S53-60
5. Slattery M.L. Diet, lifestyle, and colon cancer. Semin Gastrointest Dis 11 (2000) 142-146
6. Boutron-Ruault M.C., Senesse P., Méance S., Belghiti C., and Faivre J. Energy intake, body mass index, physical activity, and the colorectal adenoma-carcinoma sequence. Nutr Cancer 39 (2001) 50-57
7. Giovannucci E. An updated review of the epidemiological evidence that cigarette smoking increases risk of colorectal cancer. Cancer Epidemiol Biomark Prev 10 (2001) 725-731
8. Naccarati A., Pardini B., Hemminki K., and Vodicka P. Sporadic colorectal cancer and individual susceptibility: a review of the association studies investigating the role of DNA repair genetic polymorphisms. Mutat Res 635 (2007) 118-145
9. De la Chapelle A. Genetic predisposition to colorectal cancer. Nat Rev Cancer 4 (2004) 769-780
10. Ahmed F.E. Role of genes, the environment and their interactions in the etiology of inflammatory bowel diseases. Expert Rev Mol Diagn 6 (2006) 345-363
11. Hayes J.D., and Pulford D.J. The glutathione S-transferase supergene family: regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance. Crit Rev Biochem Mol Biol 30 (1995) 445-600
12. Eaton D.L., and Bammler T.K. Concise review of the glutathione S-transferases and their significance to toxicology. Toxicol Sci 49 (1999) 156-164
13. Webb G., Vaska V., Coggan M., and Board P. Chromosomal localization of the gene for the human theta class glutathione transferase (GSTT1). Genomics 33 (1996) 121-123
14. Pemble S., Schroeder K.R., Spencer S.R., Meyer D.J., Hallier E., Bolt H.M., et al. Human glutathione S-transferase theta (GSTT1): cDNA cloning and the characterization of a genetic polymorphism. Biochem J 300 (1994) 271-276
15. Butler W.J., Ryan P., and Roberts-Thomson I.C. Metabolic genotypes and risk forcolorectal cancer increased risk in individuals with glutathione transferase theta 1 (GSTT1) gene defect (Abstract). Gastroenterology 112 (1997) A542
16. Ferraz J.M., Zinzindohoué F., Lecomte T., Cugnenc P.H., Loriot M.A., Beaune P., et al. Impact of GSTT1, GSTM1, GSTP1 and NAT2 genotypes on KRAS2 and TP53 gene mutations in colorectal cancer. Int J Cancer 110 (2004) 183-187
17. Lüchtenborg M., Weijenberg M.P., Kampman E., van Muijen G.N., Roemen G.M., Zeegers M.P., et al. Cigarette smoking and colorectal cancer: APC mutations, hMLH1 expression, and GSTM1 and GSTT1 polymorphisms. Am J Epidemiol 161 (2005) 806-815
18. Lee E., Huang Y., Zhao B., Seow-Choen F., Balakrishnan A., and Chan S.H. Genetic polymorphism of conjugating enzymes and cancer risk: GSTM1, GSTT1, NAT1 and NAT2. J Toxicol Sci 23 (1998) 140-142
19. Sgambato A., Campisi B., Zupa A., Bochicchio A., Romano G., Tartarone A., et al. Glutathione S-transferase (GST) polymorphisms as risk factors for cancer in a highly homogeneous population from southern Italy. Anticancer Res 22 (2002) 3647-3652
20. Turner F., Smith G., Sachse C., Lightfoot T., Garner R.C., Wolf C.R., et al. Vegetable, fruit and meat consumption and potential risk modifying genes in relation to colorectal cancer. Int J Cancer 112 (2004) 259-264
21. Fan C.H., Jin M.J., Zhang Y., Song L., Xu H., Jiang Q.T., et al. Association between genetic polymorphisms of metabolic enzymes and susceptibility of colorectal cancer. Zhonghua Yu Fang Yi Xue Za Zhi 40 (2006) 13-17
22. Yeh C.C., Sung F.C., Tang R., Chang-Chieh C.R., and Hsieh L.L. Association between polymorphisms of biotransformation and DNA-repair genes and risk of colorectal cancer in Taiwan. J Biomed Sci 14 (2007) 183-193
23. Chenevix-Trench G., Young J., Coggan M., and Board P. Glutathione S-transferase M1 and T1 polymorphisms: susceptibility to colon cancer and age of onset. Carcinogenesis 16 (1995) 1655-1657
24. Deakin M., Elder J., Hendrickse C., Peckham D., Baldwin D., Pantin C., et al. Glutathione S-transferase GSTT1 genotypes and susceptibility to cancer: studies of interactions with GSTM1 in lung, oral, gastric and colorectal cancers. Carcinogenesis 17 (1996) 881-884
25. Katoh T., Nagata N., Kuroda Y., Itoh H., Kawahara A., Kuroki N., et al. Glutathione S-transferase M1 (GSTM1) and T1 (GSTT1) genetic polymorphism and susceptibility to gastric and colorectal adenocarcinoma. Carcinogenesis 17 (1996) 1855-1859
26. Gertig D.M., Stampfer M., Haiman C., Hennekens C.H., Kelsey K., and Hunter D.J. Glutathione S-transferase GSTM1 and GSTT1 polymorphisms and colorectal cancer risk: a prospective study. Cancer Epidemiol Biomarkers Prev 7 (1998) 1001-1005
27. Abdel-Rahman S.Z., Soliman A.S., Bondy M.L., Wu X., El-Badawy S.A., Mahgoub K.G., et al. Polymorphism of glutathione S-transferase loci GSTM1 and GSTT1 and susceptibility to colorectal cancer in Egypt. Cancer Lett 142 (1999) 97-104
28. Welfare M., Monesola Adeokun A., Bassendine M.F., and Daly A.K. Polymorphisms in GSTP1, GSTM1, and GSTT1 and susceptibility to colorectal cancer. Cancer Epidemiol Biomarkers Prev 8 (1999) 289-292
29. Zhang H., Ahmadi A., Arbman G., Zdolsek J., Carstensen J., Nordenskjöld B., et al. Glutathione S-transferase T1 and M1 genotypes in normal mucosa, transitional mucosa and colorectal adenocarcinoma. Int J Cancer 84 (1999) 135-138
30. Butler W.J., Ryan P., and Roberts-Thomson I.C. Metabolic genotypes and risk for colorectal cancer. J Gastroenterol Hepatol 16 (2001) 631-635
31. Loktionov A., Watson M.A., Gunter M., Stebbings W.S., Speakman C.T., and Bingham S.A. Glutathione-S-transferase gene polymorphisms in colorectal cancer patients: interaction between GSTM1 and GSTM3 allele variants as a risk-modulating factor. Carcinogenesis 22 (2001) 1053-1060
32. Saadat I., and Saadat M. Glutathione S-transferase M1 and T1 null genotypes and the risk of gastric and colorectal cancers. Cancer Lett 169 (2001) 21-26
33. Laso N., Lafuente M.J., Mas S., Trias M., Ascaso C., Molina R., et al. Glutathione S-transferase (GSTM1 and GSTT1)-dependent risk for colorectal cancer. Anticancer Res 22 (2002) 3399-3403
34. Sachse C., Smith G., Wilkie M.J., Barrett J.H., Waxman R., Sullivan F., et al. A pharmacogenetic study to investigate the role of dietary carcinogens in the etiology of colorectal cancer. Carcinogenesis 23 (2002) 1839-1849
35. Seow A., Yuan J.M., Sun C.L., Van Den Berg D., Lee H.P., and Yu M.C. Dietary isothiocyanates, glutathione S-transferase polymorphisms and colorectal cancer risk in the Singapore Chinese Health Study. Carcinogenesis 23 (2002) 2055-2061
36. Ye Z., and Parry J.M. Genetic polymorphisms in the cytochrome P450 1A1, glutathione S-transferase M1 and T1, and susceptibility to colon cancer. Teratog Carcinog Mutagen 22 (2002) 385-392
37. Zhu Y., Deng C., Zhang Y., Zhou X., and He X. The relationship between GSTM1, GSTT1 gene polymorphisms and susceptibility to sporadic colorectal adenocarcinoma. Zhonghua Nei Ke Za Zhi 41 (2002) 538-540
38. Nascimento H., Coy C.S., Teori M.T., Boin I.F., Góes J.R., Costa F.F., et al. Possible influence of glutathione S-transferase GSTT1 null genotype on age of onset of sporadic colorectal adenocarcinoma. Dis Colon Rectum 46 (2003) 510-515
39. van der Hel O.L., Bueno de Mesquita H.B., Roest M., Slothouber B., van Gils C., van Noord P.A., et al. No modifying effect of NAT1, GSTM1, and GSTT1 on the relation between smoking and colorectal cancer risk. Cancer Epidemiol Biomarkers Prev 12 (2003) 681-682
40. Chen K., Jiang Q.T., Ma X.Y., Yao K.Y., Leng S.G., Yu W.P., et al. Associations between genetic polymorphisms of glutathione S-transferase M1 and T1, smoking and susceptibility to colorectal cancer: a case-control study. Zhonghua Zhong Liu Za Zhi 26 (2004) 645-648
41. Kiss I., Németh A., Bogner B., Pajkos G., Orsós Z., Sándor J., et al. Polymorphisms of glutathione-S-transferase and arylamine N-acetyltransferase enzymes and susceptibility to colorectal cancer. Anticancer Res 24 (2004) 3965-3970
42. van der Logt E.M., Bergevoet S.M., Roelofs H.M., van Hooijdonk Z., te Morsche R.H., Wobbes T., et al. Genetic polymorphisms in UDP-glucuronosyltransferases and glutathione S-transferases and colorectal cancer risk. Carcinogenesis 25 (2004) 2407-2415
43. Ates N.A., Tamer L., Ates C., Ercan B., Elipek T., Ocal K., et al. Glutathione S-transferase M1, T1, P1 genotypes and risk for development of colorectal cancer. Biochem Genet 43 (2005) 149-163
44. Rajagopal R., Deakin M., Fawole A.S., Elder J.B., Elder J., Smith V., et al. Glutathione S-transferase T1 polymorphisms are associated with outcome in colorectal cancer. Carcinogenesis 26 (2005) 2157-2163
45. Yeh C.C., Hsieh L.L., Tang R., Chang-Chieh C.R., and Sung F.C. Vegetable/fruit, smoking, glutathione S-transferase polymorphisms and risk for colorectal cancer in Taiwan. World J Gastroenterol 11 (2005) 1473-1480
46. Huang K., Sandler R.S., Millikan R.C., Schroeder J.C., North K.E., and Hu J. GSTM1 and GSTT1 polymorphisms, cigarette smoking, and risk of colon cancer: a population-based case-control study in North Carolina (United States). Cancer Causes Control 17 (2006) 385-394
47. Little J., Sharp L., Masson L.F., Brockton N.T., Cotton S.C., Haites N.E., et al. Colorectal cancer and genetic polymorphisms of CYP1A1, GSTM1 and GSTT1: a case-control study in the Grampian region of Scotland. Int J Cancer 119 (2006) 2155-2164
48. Martínez C., Martín F., Fernández J.M., García-Martín E., Sastre J., Díaz-Rubio M., et al. Glutathione S-transferases mu 1, theta 1, pi 1, alpha 1 and mu 3 genetic polymorphisms and the risk of colorectal and gastric cancers in humans. Pharmacogenomics 7 (2006) 711-718
49. Probst-Hensch N.M., Sun C.L., Van Den Berg D., Ceschi M., Koh W.P., and Yu M.C. The effect of the cyclin D1 (CCND1) A870G polymorphism on colorectal cancer risk is modified by glutathione-S-transferase polymorphisms and isothiocyanate intake in the Singapore Chinese Health Study. Carcinogenesis 27 (2006) 2475-2482
50. Skjelbred C.F., Saebø M., and Hjartåker A. Meat, vegetables and genetic polymorphisms and the risk of colorectal carcinomas and adenomas. BMC Cancer 7 (2007) 228
51. Küry S., Buecher B., Robiou-du-Pont S., Scoul C., Colman H., Le Neel T., et al. Low-penetrance alleles predisposing to sporadic colorectal cancers: a French case-controlled genetic association study. BMC Cancer 8 (2008) 326
52. Epplein M., Wilkens L.R., Tiirikainen M., Dyba M., Chung F.L., Goodman M.T., et al. Urinary isothiocyanates; glutathione S-transferase M1, T1, and P1 polymorphisms; and risk of colorectal cancer: the Multiethnic Cohort Study. Cancer Epidemiol Biomarkers Prev 18 (2009) 314-320
53. Chen K., Jiang Q.T., and He H.Q. Relationship between metabolic enzyme polymorphism and colorectal cancer. World J Gastroenterol 11 (2005) 331-335
54. Garte S. The role of ethnicity in cancer susceptibility gene polymorphisms: the example of CYP1A1. Carcinogenesis 19 (1998) 1329-1332
55. Garte S., Gaspari L., Alexandrie A.K., Ambrosone C., Autrup H., Autrup J.L., et al. Metabolic gene polymorphism frequencies in control populations. Cancer Epidemiol. Biomarkers Prev 10 (2001) 1239-1248
56. Saadat M., Saadat I., Saboori Z., and Emad A. Combination of CC16, GSTM1, and GSTT1 genetic polymorphisms is associated with asthma. J Allergy Clin Immunol 113 (2004) 996-998
57. Doney A.S., Lee S., Leese G.P., Morris A.D., and Palmer C.N. Increased cardiovascular morbidity and mortality in type 2 diabetes is associated with the glutathione S transferase theta-null genotype: a Go-DARTS study. Circulation 111 (2005) 2927-2934
58. Raimondi S., Botteri E., Iodice S., Lowenfels A.B., and Maisonneuve P. Gene-smoking interaction on colorectal adenoma and cancer risk: Review and meta-analysis. Mutat Res 670 (2009) 6-14
59. Grubben M.J., Nagengast F.M., Katan M.B., and Peters W.H. The glutathione biotransformation system and colorectal cancer risk in humans. Scand J Gastroenterol Suppl 234 (2001) 68-76
60. Sherratt P.J., Manson M.M., Thomson A.M., Hissink E.A., Neal G.E., van Bladeren P.J., et al. Increased bioactivation of dihaloalkanes in rat liver due to induction of class theta glutathione S-transferase T1-1. Biochem J 335 (1998) 619-630
61. Boccia S., La Torre G., Gianfagna F., Mannocci A., and Ricciardi G. Glutathione S-transferase T1 status and gastric cancer risk: a meta-analysis of the literature. Mutagenesis 21 (2006) 115-123
62. Saadat M. Genetic polymorphisms of glutathioneS-transferase T1 (GSTT1) and susceptibility to gastric cancer: a meta-analysis. Cancer Sci 97 (2006) 505-509
63. Abdel-Rahman S.Z., Anwar W.A., Abdel-Aal W.E., Mostafa H.M., and Au W.W. GSTM1 and GSTT1 genes are potential risk modifiers for bladder cancer. Cancer Detect Prev 22 (1998) 129-138
64. Grando J.P., and Kuasne H. Association between polymorphisms in the biometabolism genes CYP1A1, GSTM1, GSTT1 and GSTP1 in bladder cancer. Clin Exp Med 9 (2009) 21-28
65. Sadetzki S., Bensal D., Novikov I., and Modan B. The limitations of using hospital controls in cancer etiology-one more example for Berkson's bias. Eur J Epidemiol 18 (2003) 1127-1131